Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax

JAMA

Volumn 282, Issue 22, 1999, Pages 2104-2106

  Friedlander, Arthur M ^a   Pittman, Phillip R ^a   Parker, Gerald W ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE; UNCLASSIFIED DRUG; VACCINE;

ANTHRAX; BACILLUS ANTHRACIS; DRUG EFFICACY; DRUG SAFETY; GEOGRAPHIC DISTRIBUTION; HISTORY OF MEDICINE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; VACCINATION;

EID: 0033536997     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.22.2104     Document Type: Short Survey

References (20)

1. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. JAMA. 1999;281:1735-1745.
2. Friedlander AM. Anthrax. In: Sidell FR, Takafuji ET, Franz DR, eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General, US Dept of the Army; 1997:467-478.
3. Brachman P, Friedlander AM. Anthrax. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1999:629-637.
4. Anthrax vaccine adsorbed [package insert]. Lansing, Michigan Dept of Public Health; 1978.
5. Congressional Testimony before Subcommittee on National Security, Veterans Affairs, and International Relations. (April 29, 1999) (testimony of KC Zoon).
6. Congressional Testimony before Subcommittee on National Security, Veterans Affairs, and International Relations. (July 21, 1999) (testimony of SS Ellenberg).
7. Brachman PS, Gold H, Plotkin SA, Fekety FR, Werrin M, Ingraham NR. Field evaluation of a human anthrax vaccine. Am J Public Health. 1962;52: 632-645.
8. 50 Federal Register 51058 (1985).
9. Turnbull PCB, Broster MG, Carman JA, Manchee RJ, Melling J. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun. 1986;52: 356-363.
10. Little SF, Knudson GB. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect Immun. 1986;52:509-512.
11. Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect Immun. 1992;60:662-668.
12. Ivins BE, Fellows PF, Nelson GO. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine. 1994;12: 872-874.
13. Fellows PF, Linscott MK, Ivins BE. Anthrax vaccine efficacy against Bacillus anthracis strains of diverse geographical origin. Presented at: 3rd International Conference on Anthrax; September 1998; Plymouth, England.
14. Ivins BE, Fellows P, Pitt L, etal. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine. 1995;13: 1779-1784.
15. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental inhalation anthrax in the rhesus monkey. Lab Invest. 1995;73:691-702.
16. Ivins BE, Fellows PF, Pitt MLM, et al. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med Bull. 1996;87:125-126.
17. Pitt MLM, Ivins BE, Estep JE, Farchaus J, Friedlander AM. Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalation anthrax. Salisbury Med Bull. 1996;87:130.
18. Ivins BE, Pitt MLM, Fellow PF, et al. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine. 1998;16:1141-1148.
19. Pitt MLM, Little S, Ivins BE, et al. In vitro correlate of immunity in an animal model of inhalational anthrax. J Appl Microbiol. 1999;87:304.
20. Auerbach S, Wright GG. Studies on immunity in anthrax, VI: immunizing activity of protective antigen against various strains of Bacillus anthracis. J Immunol. 1955;75:129-133.